Kindeva Drug Delivery Limited – FDA 483, Apr 15, 2013
An FDA inspection of 3M Health Care, Ltd. in Loughborough, United Kingdom, identified significant issues in their pharmaceutical manufacturing processes. Observations included reactive drug product containers leading to product delivery failures, inadequate analytical equipment logbooks lacking essential batch information, and a failure by the Quality Control Unit to formally approve changes to analytical test procedures for over six years. These findings highlight deficiencies in quality control and manufacturing oversight.
- Person
ID · e2202e78-a597-488c-8aa0-94c6d3e2da9c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.